AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 181 min read$OMDA

Duffy Sean P. sold $260K of OMDA

Duffy Sean P. (Chief Executive Officer) sold 14,960 shares of Omada Health, Inc. (OMDA) at $17.36 ($0.26M total) on 2026-06-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Duffy Sean P.
Published Jun 18, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 11:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure adds transparency on insider transactions but does not include new guidance, financial results, or company-specific catalysts.

02

Market read

Traders may treat this as low-signal sentiment data rather than a fundamental catalyst.

03

What to watch

The article provides no context on total compensation, tax obligations, or whether other insiders are selling/buying around the same period.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-18, transaction dated 2026-06-16.

Background

The article is an SEC Form 4 disclosure of an insider sale by Omada Health CEO Sean Duffy.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CEO Sean Duffy sold 14,960 shares in an open-market transaction at $17.3604 on 2026-06-16, per Form 4.

Expected impact

Likely minimal immediate price impact; any effect is more about sentiment than new company information.

Evidence & confidence

The filing is an SEC Form 4 insider transaction and explicitly notes a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Sector

No clear sector read-through; this is company-specific insider activity without operational or regulatory updates.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with 10b5-1, repeated insider selling can coincide with valuation or liquidity needs, so traders may still watch for follow-on selling patterns.

Key entities

  • issuer
    Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Sean P. Duffy

    CEO and director who sold shares under a 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

OMDA insider trading history →

Related articles

OCT 20
$OMDALowAI 8/10

Omada Health reports weight loss study results for GLP-1 program

Omada Health (NASDAQ:OMDA) presented a 12-week study at the World Obesity and Weight Management Congress, showing its GLP-1 Care Track program led to 6.0% average weight loss vs. 3.3% for usual care. The study, published in Diabetes, Obesity and Metabolism, involved 245 adults with obesity. Omada's program also improved body composition, well-being, and reduced depression/anxiety symptoms.

investing.com2 min
AUG 13
$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

fool.com6 min
AUG 6
$OMDAHigh

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch

SEC EDGAR 8-K6 min
OCT 23
$RENTMed

Nexus Capital Management LP (Cohen Michael S, Flesh Daniel E.) purchased $2.2M of RENT (indirect holdings)

Nexus Capital Management LP purchased 632,922 indirectly-held shares of Rent the Runway, Inc. (RENT) at $3.55 ($2.25M total) on 2026-10-21. Filed jointly with Gateway Runway, LLC (Director), Gateway Runway Intermediate Holdings, Inc. (Director), NEXUS SPECIAL SITUATIONS III, L.P. (Director), NEXUS SPECIAL SITUATIONS III (CAYMAN), L.P. (Director), Nexus Special Situations GP III, LP (Director), Nexus Partners III, LLC (Director), Cohen Michael S (Director), Flesh Daniel E. (Director) and Giangiacomo Damian (Director).

SEC EDGAR1 min